Literature DB >> 14738238

Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis.

P A de Jong1, Y Nakano, M H Lequin, J R Mayo, R Woods, P D Paré, H A W M Tiddens.   

Abstract

For effective clinical management of cystic fibrosis (CF) lung disease it is important to closely monitor the start and progression of lung damage. The aim of this study was to investigate the ability of high-resolution computed tomography (HRCT) scoring systems and pulmonary function tests (PFT) to detect changes in lung disease. CF children (n=48) had two HRCT scans in combination with two PFT 2 yrs apart. Their scans were scored using five scoring systems (Castile, Brody, Helbich, Santamaria and Bhalla). "Sensitivity" was defined as the ability to detect disease progression. In this group of children, HRCT scores worsened. PFT remained unchanged or improved. Of the HRCT parameters, mucous plugging and the severity, extent and peripheral extension of bronchiectasis worsened significantly. Relationships between changes in HRCT scores and PFT were weak. Substantial structural lung damage was evident in some children who had normal lung function. These data show that high-resolution computed tomography is more sensitive than pulmonary function tests in the detection of early and progressive lung disease, and suggest that high-resolution computed tomography may be useful in the follow up of cystic fibrosis children and as an outcome measure in studies that aim to reduce lung damage.

Entities:  

Mesh:

Year:  2004        PMID: 14738238     DOI: 10.1183/09031936.03.00006603

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  68 in total

1.  Assessment of lung disease in children with cystic fibrosis using hyperpolarized 3-Helium MRI: comparison with Shwachman score, Chrispin-Norman score and spirometry.

Authors:  Edwin J R van Beek; Catherine Hill; Neil Woodhouse; Stanislao Fichele; Sally Fleming; Bridget Howe; Sandra Bott; Jim M Wild; Christopher J Taylor
Journal:  Eur Radiol       Date:  2006-08-29       Impact factor: 5.315

2.  Fifty-year perspective of "cystic fibrosis of the pancreas".

Authors:  Alexander Spock
Journal:  Pediatr Radiol       Date:  2005-08

3.  Is limited computed tomography the future for imaging the lungs of children with cystic fibrosis?

Authors:  S C Langton Hewer
Journal:  Arch Dis Child       Date:  2006-05       Impact factor: 3.791

4.  Computed tomography dose and variability of airway dimension measurements: how low can we go?

Authors:  Pim A de Jong; Frederick R Long; Yasutaka Nakano
Journal:  Pediatr Radiol       Date:  2006-08-10

5.  High resolution computed tomography of the chest in cystic fibrosis (CF): is simplification of scoring systems feasible?

Authors:  Anastasia Oikonomou; John Tsanakas; Elpis Hatziagorou; Fotios Kirvassilis; Stavros Efremidis; Panos Prassopoulos
Journal:  Eur Radiol       Date:  2007-11-27       Impact factor: 5.315

Review 6.  Advancing outcome measures for the new era of drug development in cystic fibrosis.

Authors:  Nicole Mayer-Hamblett; Bonnie W Ramsey; Richard A Kronmal
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

Review 7.  Chest imaging in cystic fibrosis studies: What counts, and can be counted?

Authors:  Rhonda Szczesniak; Lidija Turkovic; Eleni-Rosalina Andrinopoulou; Harm A W M Tiddens
Journal:  J Cyst Fibros       Date:  2016-12-28       Impact factor: 5.482

Review 8.  [Magnetic resonance imaging of respiratory movement and lung function].

Authors:  R Tetzlaff; M Eichinger
Journal:  Radiologe       Date:  2009-08       Impact factor: 0.635

9.  Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis.

Authors:  Don B Sanders; Zhanhai Li; Alan S Brody; Philip M Farrell
Journal:  Am J Respir Crit Care Med       Date:  2011-10-01       Impact factor: 21.405

10.  Changes in Pulmonary Function and Controlled Ventilation-High Resolution CT of Chest After Antibiotic Therapy in Infants and Young Children with Cystic Fibrosis.

Authors:  Shahid I Sheikh; Frederick R Long; Robert Flucke; Nancy A Ryan-Wenger; Don Hayes; Karen S McCoy
Journal:  Lung       Date:  2015-03-12       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.